Home › Trial NCT02414776
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
- Trial IDNCT02414776
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorWestern Regional Medical Center
- Enrollment3
- Start date2014-07
- ConditionsEstrogen Receptor Positive Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.